Criticismfor Food and Drug Administration’s approval of new painkiller Dsuvia, 1,000 stronger than morphine

The Food and Drug Administration has come under harsh criticism for approving a painkiller called Dsuvia which is 1,000 times stronger than morphine.  FDA commissioner Scott Gottlieb, MD, addressed the timing in a statement released late last week. “The crisis of opioid addiction is an issue of great concern for our nation,” he said. “Addressing it is a public health priority for the FDA. The agency is taking new steps to more actively confront this crisis while also paying careful attention to the needs of patients and physicians managing pain.”

Critics cite the fact that the opioid epidemic is still rising and has resulted in the deaths of over 72,000 people in the U.S.

Dsuvia is taken under the tongue and is a synthetic opioid that is delivered through a disposable, pre-filled, single-dose applicator, the FDA says. It is restricted to being used in certified medically supervised healthcare settings like hospitals, surgical centers, and emergency departments. Dsuvia works like  morphine and other opioids do by binding to opioid receptors in the body to block pain . However, it is 1,000 times stronger.